Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Catalent, Inc. (CTLT) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Catalent, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1596783.
Total stock buying since 2015: $5,376,345.
Total stock sales since 2015: $2,137,153,103.
Total stock option exercises since 2015: $62,473,161.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 26,785 | $1,571,905 | 0 | $0 |
| 2023 | 22,000 | $1,105,020 | 12,800 | $597,423 | 0 | $0 |
| 2022 | 0 | $0 | 598,477 | $61,405,820 | 0 | $0 |
| 2021 | 0 | $0 | 3,571,573 | $455,798,782 | 356,365 | $14,871,716 |
| 2020 | 2,000 | $119,420 | 5,660,139 | $558,555,574 | 235,766 | $7,051,710 |
| 2019 | 58,500 | $2,646,125 | 231,126 | $11,280,536 | 406,838 | $7,448,376 |
| 2018 | 23,000 | $918,930 | 195,669 | $8,635,440 | 480,142 | $9,436,693 |
| 2017 | 17,500 | $586,850 | 311,298 | $10,215,270 | 665,127 | $8,048,211 |
| 2016 | 0 | $0 | 25,907,441 | $619,179,716 | 89,124 | $1,438,728 |
| 2015 | 0 | $0 | 38,527,267 | $409,912,637 | 1,243,733 | $14,177,727 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-21 | Gennadios Aristippos (President Softgel & Oral Tech) | Option Ex | 13,662 | 30.23 | 413,002 |
| 2020-11-23 | Zippelius Peter (Director) | Sale | 5,392,280 | 99.26 | 535,237,712 |
| 2020-11-11 | Fasman Steven L (SVP & General Counsel) | Sale | 2,425 | 100.99 | 244,900 |
| 2020-10-14 | Schmidt Kay A (SVP, Technical Operations) | Sale | 2,985 | 93.54 | 279,216 |
| 2020-10-14 | Fasman Steven L (SVP & General Counsel) | Sale | 5,510 | 93.42 | 514,738 |
| 2020-10-14 | Fasman Steven L (SVP & General Counsel) | Option Ex | 15,025 | 28.20 | 423,705 |
| 2020-10-12 | Grippo Michael J (SVP, Strategy & Corp. Dev.) | Sale | 1,680 | 94.99 | 159,583 |
| 2020-10-07 | Arnold Jonathan (Pres. Oral & Specialty Deliv.) | Sale | 15,928 | 91.50 | 1,457,412 |
| 2020-10-07 | Arnold Jonathan (Pres. Oral & Specialty Deliv.) | Option Ex | 39,342 | 36.28 | 1,427,367 |
| 2020-10-02 | Gunther Scott (SVP, Quality & Reg. Affairs) | Sale | 4,359 | 85.65 | 373,361 |
| 2020-10-02 | Gunther Scott (SVP, Quality & Reg. Affairs) | Option Ex | 7,347 | 36.02 | 264,638 |
| 2020-10-02 | Chiminski John R (Chair & CEO) | Sale | 182,231 | 85.66 | 15,609,907 |
| 2020-10-02 | Chiminski John R (Chair & CEO) | Option Ex | 138,135 | 28.20 | 3,895,407 |
| 2020-09-02 | Grippo Michael J (SVP, Strategy & Corp. Dev.) | Sale | 2,250 | 89.75 | 201,937 |
| 2020-07-30 | Lucier Gregory T | Sale | 24,000 | 90.09 | 2,162,160 |
| 2020-06-29 | Gunther Scott (SVP, Quality & Reg. Affairs) | Sale | 2,824 | 72.24 | 204,005 |
| 2020-06-25 | Gennadios Aristippos (President Softgel & Oral Tech) | Sale | 8,325 | 73.00 | 607,725 |
| 2020-06-25 | Gennadios Aristippos (President Softgel & Oral Tech) | Option Ex | 22,255 | 28.20 | 627,591 |
| 2020-02-13 | Lucier Gregory T | Buy | 2,000 | 59.71 | 119,420 |
| 2020-01-13 | Grippo Michael J (SVP, Strategy & Corp. Dev.) | Sale | 1,680 | 58.00 | 97,440 |
| 2019-12-20 | Grippo Michael J (SVP, Strategy & Corp. Dev.) | Sale | 2,406 | 56.00 | 134,736 |
| 2019-12-19 | Grippo Michael J (SVP, Strategy & Corp. Dev.) | Sale | 1,846 | 54.00 | 99,684 |
| 2019-12-16 | Maselli Alessandro (President & COO) | Sale | 7,268 | 53.18 | 386,512 |
| 2019-11-26 | Pravda Ricardo (SVP & Chief HR Officer) | Sale | 2,612 | 52.73 | 137,717 |
| 2019-11-25 | Gennadios Aristippos (President Softgel & Oral Tech) | Sale | 45,256 | 52.55 | 2,378,202 |
| 2019-11-25 | Gennadios Aristippos (President Softgel & Oral Tech) | Option Ex | 123,880 | 15.72 | 1,947,765 |
| 2019-11-22 | Grippo Michael J (SVP, Strategy & Corp. Dev.) | Sale | 376 | 52.00 | 19,552 |
| 2019-10-07 | Chiminski John R (Chair & CEO) | Sale | 97,043 | 48.84 | 4,739,580 |
| 2019-10-07 | Chiminski John R (Chair & CEO) | Option Ex | 47,552 | 24.35 | 1,157,891 |
| 2019-09-09 | Lucier Gregory T | Buy | 2,000 | 51.64 | 103,280 |
| 2019-07-12 | Littlejohns Barry (President, Biologics & SDD) | Sale | 15,940 | 53.91 | 859,325 |
| 2019-07-12 | Littlejohns Barry (President, Biologics & SDD) | Option Ex | 49,212 | 19.05 | 937,636 |
| 2019-07-11 | Fasman Steven L (SVP & General Counsel) | Sale | 4,053 | 54.04 | 219,024 |
| 2019-07-11 | Fasman Steven L (SVP & General Counsel) | Option Ex | 27,146 | 26.89 | 729,874 |
| 2019-05-29 | Buzy Peter L (President, Gene Therapy) | Buy | 44,500 | 45.13 | 2,008,285 |
| 2019-05-28 | Joseph Wetteny (SVP & Chief Financial Officer) | Option Ex | 9,453 | 10.71 | 101,241 |
| 2019-05-15 | Morel Donald E Jr | Buy | 10,000 | 44.44 | 444,400 |
| 2019-05-09 | Lucier Gregory T | Buy | 2,000 | 45.08 | 90,160 |
| 2019-03-21 | Gennadios Aristippos (President, Softgel Tech.) | Sale | 3,392 | 42.54 | 144,295 |
| 2019-03-21 | Gennadios Aristippos (President, Softgel Tech.) | Option Ex | 13,528 | 10.71 | 144,884 |
| 2019-03-07 | Miyamoto Lance (SVP, Human Resources) | Sale | 43,619 | 42.52 | 1,854,679 |
| 2019-03-07 | Miyamoto Lance (SVP, Human Resources) | Option Ex | 123,610 | 17.07 | 2,109,775 |
| 2019-02-15 | Downie William (SVP, Global Sales & Marketing) | Sale | 7,315 | 42.00 | 307,230 |
| 2019-02-15 | Downie William (SVP, Global Sales & Marketing) | Option Ex | 12,457 | 25.63 | 319,310 |
| 2018-11-08 | Greisch John J | Buy | 13,000 | 37.61 | 488,930 |
| 2018-10-16 | Miyamoto Lance (SVP, Human Resources) | Sale | 6,525 | 42.50 | 277,312 |
| 2018-10-16 | Miyamoto Lance (SVP, Human Resources) | Option Ex | 18,000 | 12.14 | 218,520 |
| 2018-10-15 | Littlejohns Barry (President, Biologics & SDD) | Sale | 47,265 | 41.64 | 1,968,114 |
| 2018-10-15 | Littlejohns Barry (President, Biologics & SDD) | Option Ex | 144,811 | 14.86 | 2,151,891 |
| 2018-10-01 | Chiminski John R (Chair, President & CEO) | Sale | 130,545 | 45.32 | 5,916,299 |
| 2018-10-01 | Chiminski John R (Chair, President & CEO) | Option Ex | 286,358 | 21.98 | 6,293,576 |
| 2018-09-13 | Morel Donald E Jr | Buy | 10,000 | 43.00 | 430,000 |
| 2018-06-20 | Fasman Steven L (SVP & General Counsel) | Sale | 2,252 | 41.78 | 94,088 |
| 2018-06-20 | Fasman Steven L (SVP & General Counsel) | Option Ex | 15,458 | 24.26 | 375,011 |
| 2018-03-08 | Downie William (SVP, Global Sales & Marketing) | Sale | 9,082 | 41.80 | 379,627 |
| 2018-03-08 | Downie William (SVP, Global Sales & Marketing) | Option Ex | 15,515 | 25.63 | 397,695 |
| 2017-12-12 | Chiminski John R (Chair, President & CEO) | Sale | 78,190 | 39.51 | 3,089,286 |
| 2017-12-11 | Chiminski John R (Chair, President & CEO) | Sale | 103,268 | 39.70 | 4,099,739 |
| 2017-12-11 | Chiminski John R (Chair, President & CEO) | Option Ex | 206,685 | 10.71 | 2,213,596 |
| 2017-11-21 | Roehrhoff Uwe | Buy | 7,500 | 39.22 | 294,150 |
| 2017-08-29 | Dolan Christine (SVP - Product Development) | Sale | 1,594 | 38.75 | 61,767 |
| 2017-08-29 | Dolan Christine (SVP - Product Development) | Option Ex | 9,150 | 18.57 | 169,915 |
| 2017-08-29 | Miyamoto Lance (SVP - Human Resources) | Sale | 8,512 | 38.22 | 325,328 |
| 2017-08-29 | Miyamoto Lance (SVP - Human Resources) | Option Ex | 39,138 | 12.14 | 475,135 |
| 2017-08-01 | Dolan Christine (SVP - Product Development) | Sale | 745 | 34.85 | 25,963 |
| 2017-06-09 | Walsh Matthew M (See Remarks) | Sale | 2,759 | .00 | 0 |
| 2017-06-08 | Walsh Matthew M (See Remarks) | Sale | 24,989 | .00 | 0 |
| 2017-06-08 | Walsh Matthew M (See Remarks) | Option Ex | 74,651 | 12.79 | 954,413 |
| 2017-04-25 | Johnson Sharon (See Remarks) | Sale | 9,160 | 29.00 | 265,640 |
| 2017-04-25 | Johnson Sharon (See Remarks) | Option Ex | 70,716 | 16.86 | 1,192,554 |
| 2017-03-20 | Downie William (See Remarks) | Sale | 8,262 | 28.60 | 236,293 |
| 2017-03-20 | Downie William (See Remarks) | Option Ex | 58,103 | 14.27 | 829,013 |
| 2017-03-20 | Chiminski John R (See Remarks) | Sale | 201 | 28.76 | 5,780 |
| 2017-03-16 | Chiminski John R (See Remarks) | Sale | 73,618 | 28.60 | 2,105,474 |
| 2017-03-16 | Chiminski John R (See Remarks) | Option Ex | 206,684 | 10.71 | 2,213,585 |
| 2017-02-15 | Morel Donald E Jr | Buy | 10,000 | 29.27 | 292,700 |
| 2016-09-09 | Schwarzman Stephen A (10% Owner) | Sale | 17,100,705 | 23.58 | 403,234,623 |
| 2016-06-09 | Schwarzman Stephen A (10% Owner) | Sale | 8,785,539 | 24.51 | 215,333,560 |
| 2016-05-27 | Walsh Matthew M (See Remarks) | Sale | 21,197 | 28.85 | 611,533 |
| 2016-05-27 | Walsh Matthew M (See Remarks) | Option Ex | 89,124 | 16.14 | 1,438,728 |
| 2015-08-19 | Chiminski John R (See Remarks) | Sale | 2,955 | 33.93 | 100,263 |
| 2015-08-17 | Chiminski John R (See Remarks) | Sale | 35,550 | 33.80 | 1,201,590 |
| 2015-08-17 | Chiminski John R (See Remarks) | Option Ex | 100,000 | 10.71 | 1,071,000 |
| 2015-08-03 | Chiminski John R (See Remarks) | Sale | 35,277 | 33.85 | 1,194,126 |
| 2015-08-03 | Chiminski John R (See Remarks) | Option Ex | 100,000 | 10.71 | 1,071,000 |
| 2015-07-27 | Walsh Matthew M (See Remarks) | Sale | 27,172 | 31.18 | 847,222 |
| 2015-07-27 | Walsh Matthew M (See Remarks) | Option Ex | 84,717 | 11.90 | 1,008,386 |
| 2015-07-20 | Chiminski John R (See Remarks) | Sale | 33,081 | 29.40 | 972,581 |
| 2015-07-20 | Chiminski John R (See Remarks) | Option Ex | 100,000 | 10.71 | 1,071,000 |
| 2015-07-06 | Chiminski John R (See Remarks) | Sale | 33,828 | 29.34 | 992,513 |
| 2015-07-06 | Chiminski John R (See Remarks) | Option Ex | 100,000 | 10.71 | 1,071,000 |
| 2015-06-11 | Schwarzman Stephen A (10% Owner) | Sale | 1,844,963 | 28.13 | 51,898,809 |
| 2015-06-08 | Schwarzman Stephen A (10% Owner) | Sale | 12,299,753 | 28.13 | 345,992,051 |
| 2015-04-06 | Walsh Matthew M (See Remarks) | Sale | 34,439 | 30.43 | 1,047,978 |
| 2015-04-06 | Walsh Matthew M (See Remarks) | Option Ex | 102,043 | 10.71 | 1,092,880 |
| 2015-04-01 | Gennadios Aristippos (See Remarks) | Sale | 24,868 | 30.61 | 761,209 |
| 2015-04-01 | Gennadios Aristippos (See Remarks) | Option Ex | 65,464 | 11.57 | 757,287 |
| 2015-04-01 | Houlton Scott (See Remarks) | Sale | 16,253 | 30.61 | 497,504 |
| 2015-04-01 | Houlton Scott (See Remarks) | Option Ex | 98,035 | 14.68 | 1,438,663 |
| 2015-03-27 | Leonard Stephen (See Remarks) | Sale | 31,005 | 30.13 | 934,180 |
| 2015-03-27 | Leonard Stephen (See Remarks) | Option Ex | 136,000 | 10.71 | 1,456,560 |
| 2015-03-09 | Schwarzman Stephen A (10% Owner) | Sale | 23,982,522 | .00 | 0 |
| 2015-02-17 | Kurt Nielsen (See Remarks) | Sale | 20,000 | 27.41 | 548,200 |
| 2015-02-17 | Kurt Nielsen (See Remarks) | Option Ex | 48,040 | 10.71 | 514,508 |
| 2015-02-17 | Houlton Scott (See Remarks) | Sale | 13,138 | 27.42 | 360,243 |
| 2015-02-17 | Houlton Scott (See Remarks) | Option Ex | 31,210 | 10.71 | 334,259 |
| 2015-02-17 | Downie William (See Remarks) | Sale | 45,000 | 27.82 | 1,251,900 |
| 2015-02-17 | Downie William (See Remarks) | Option Ex | 138,969 | 10.71 | 1,488,357 |
| 2015-02-17 | Johnson Sharon (See Remarks) | Sale | 24,683 | 27.40 | 676,314 |
| 2015-02-17 | Johnson Sharon (See Remarks) | Option Ex | 77,852 | 14.71 | 1,145,202 |
| 2015-02-13 | Houlton Scott (See Remarks) | Sale | 1,400 | 28.28 | 39,592 |
| 2015-02-13 | Houlton Scott (See Remarks) | Option Ex | 3,293 | 10.71 | 35,268 |
| 2015-02-13 | Leonard Stephen (See Remarks) | Sale | 1,000 | 28.34 | 28,340 |
| 2015-02-13 | Leonard Stephen (See Remarks) | Option Ex | 2,508 | 10.71 | 26,860 |
| 2015-02-13 | Downie William (See Remarks) | Sale | 1,080 | 27.86 | 30,088 |
| 2015-02-13 | Downie William (See Remarks) | Option Ex | 6,202 | 10.71 | 66,423 |
| 2015-02-13 | Johnson Sharon (See Remarks) | Sale | 16,100 | 27.82 | 447,982 |
| 2015-02-13 | Johnson Sharon (See Remarks) | Option Ex | 49,400 | 10.71 | 529,074 |
| 2015-02-13 | Walsh Matthew M (See Remarks) | Sale | 3,200 | 28.11 | 89,952 |
Insider trading activities including stock purchases, stock sales, and option exercises of CTLT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Catalent, Inc. (symbol CTLT, CIK number 1596783) see the Securities and Exchange Commission (SEC) website.